Range
30.69 - 32.06
Vol / Avg.
112.3K/943.3K
Div / Yield
-
52 Wk
14.63 - 43.26
Mkt Cap
923.8M
Payout Ratio
-
Open
31.12
P/E
-
EPS
-0.52
Shares
29.4M
Outstanding
29.4M
Total Float
21.2M
Benzinga - Jun 23, 2021, 7:47AM
Benzinga - Jun 23, 2021, 6:48AM
Benzinga - Jun 21, 2021, 5:04AM
Benzinga - Jun 16, 2021, 6:55AM
Benzinga - Jun 14, 2021, 4:01PM
Benzinga - Jun 14, 2021, 1:45PM
Benzinga - Jun 14, 2021, 1:34PM
Benzinga - Jun 14, 2021, 11:25AM
Benzinga - Jun 14, 2021, 11:19AM
Benzinga - Jun 14, 2021, 10:12AM
Benzinga - Jun 14, 2021, 10:07AM
Benzinga - Jun 14, 2021, 8:39AM
Benzinga - Jun 14, 2021, 8:32AM
Benzinga - Jun 14, 2021, 8:03AM
Benzinga - Jun 14, 2021, 8:01AM
Benzinga - May 20, 2021, 7:24AM
Benzinga - May 17, 2021, 6:23AM
Benzinga - May 11, 2021, 9:35AM
Benzinga - May 11, 2021, 8:12AM
Benzinga - Mar 22, 2021, 8:04AM
load more
Sector: Health Care.Industry: Biotechnology
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-12
REV
Q1 2021Est.ActualSurprise
EPS-0.710-0.660 0.0500
REV870.000K1.222M352.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
RAPTRAPT Therapeutics1.78%923.8M

RAPT Therapeutics Frequently Asked Questions

Q

How do I buy RAPT Therapeutics (RAPT) stock?

A

You can purchase shares of RAPT Therapeutics (NASDAQ: RAPT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are RAPT Therapeutics's (RAPT) competitors?

A

Other companies in RAPT Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Humanigen (NASDAQ:HGEN), Immatics (NASDAQ:IMTX) and ChemoCentryx (NASDAQ:CCXI).

Q

What is the target price for RAPT Therapeutics (RAPT) stock?

A

The latest price target for RAPT Therapeutics (NASDAQ: RAPT) was reported by HC Wainwright & Co. on June 23, 2021. The analyst firm set a price target for 56.00 expecting RAPT to rise to within 12 months (a possible 78.00% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for RAPT Therapeutics (RAPT)?

A

The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $31.46 last updated Today at 7:14:30 PM.

Q

Does RAPT Therapeutics (RAPT) pay a dividend?

A

There are no upcoming dividends for RAPT Therapeutics.

Q

When is RAPT Therapeutics (NASDAQ:RAPT) reporting earnings?

A
RAPT Therapeutics’s Q2 earnings are confirmed for after-market on August 12, 2021.
Q

Is RAPT Therapeutics (RAPT) going to split?

A

There is no upcoming split for RAPT Therapeutics.

Q

What sector and industry does RAPT Therapeutics (RAPT) operate in?

A

RAPT Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.